BRIEF published on 11/19/2025 at 23:05, 15 days 16 hours ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 15 days 16 hours ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 21 days 16 hours ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 21 days 16 hours ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 3 months 15 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 3 months 15 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 3 months 17 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 3 months 17 days ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 5 months 17 days ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 5 months 17 days ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
Published on 12/05/2025 at 15:00, 38 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 13 hours 3 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 15:05, 33 minutes ago Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 16 minutes ago EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 21 minutes ago Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 28 minutes ago The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 53 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 15:10, 27 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 6 hours 53 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 38 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 53 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 54 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
